DERMA WHITECITY BLOCK ANTI-POLLUTION SPF40 (CLINIQUE LABS INC)
Welcome to the PulseAid listing for the DERMA WHITE drug offered from CLINIQUE LABS INC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | CLINIQUE LABS INC |
NON-PROPRIETARY NAME: | OCTINOXATE, TITANIUM DIOXIDE, OCTISALATE |
SUBSTANCE NAME: | OCTINOXATE; TITANIUM DIOXIDE; OCTISALATE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2010-10-01 |
END MARKETING DATE: | 0000-00-00 |
DERMA WHITE CITY BLOCK ANTI-POLLUTION SPF40 HUMAN OTC DRUG Details:
Item Description | DERMA WHITE CITY BLOCK ANTI-POLLUTION SPF40 from CLINIQUE LABS INC |
LABELER NAME: | CLINIQUE LABS INC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 7.5; 5.2; 2(mL/100mL; mL/100mL; mL/100mL) |
START MARKETING DATE: | 2010-10-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 49527-008_ff0d1114-24c2-4367-a60d-b1e144649925 |
PRODUCT NDC: | 49527-008 |
APPLICATION NUMBER: | part352 |
Other OCTINOXATE; TITANIUM DIOXIDE; OCTISALATE Pharmaceutical Manufacturers / Labelers: